Literature DB >> 16274801

Hemorrhage risk after quinsy tonsillectomy.

Roland Giger1, Basile Nicolas Landis, Pavel Dulguerov.   

Abstract

BACKGROUND: The goal of the study was to evaluate the incidence and possible predictive factors of post-tonsillectomy hemorrhage (PTH) in patients with peritonsillar abscess, treated by acute abscess tonsillectomy.
METHODS: A retrospective cohort study was performed on 205 patients who underwent bilateral abscess tonsillectomy under general anesthesia. Age, sex, smoking habits, history of recurrent tonsillitis or prior peritonsillar abscess, current medical treatment, side of the peritonsillar abscess, initial treatment, surgeon's experience, procedure duration, intra- and postoperative anti-inflammatory medications, and side of bleeding were analyzed.
RESULTS: Bleeding occurred in 27 patients (13%). Ipsilateral hemorrhage was observed in 8 patients (4%) and contralateral hemorrhage in 19 patients (9%). The higher incidence of PTH in the side contralateral to the abscess was found to be statistically significant (P = 0.02). Male gender (P = 0.042), smoking (P = 0.009), and aspirin intake (P = 0.008) were statistically significant factors associated with an increased PTH risk.
CONCLUSION: The risk of bleeding following abscess tonsillectomy seems higher than reported in elective tonsillectomy. This high incidence is mainly due to patients with prior aspirin intake or to bleeding in the side contralateral to the abscess. Postoperative bleeding could be reduced by performing a unilateral acute abscess tonsillectomy in selected patients. An algorithm is proposed for the management of peritonsillar abscess based on age, prior history of pharyngo-tonsillar infections, aspirin intake, and clinical improvement after initial drainage and antibiotherapy. EBM RATING: C.

Entities:  

Mesh:

Year:  2005        PMID: 16274801     DOI: 10.1016/j.otohns.2005.07.013

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

1.  Gender-specific risk factors in post-tonsillectomy hemorrhage.

Authors:  Annekatrin Coordes; Janina Soudry; Veit Maria Hofmann; Minoo Lenarz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-21       Impact factor: 2.503

Review 2.  Indications for tonsillectomy stratified by the level of evidence.

Authors:  Jochen P Windfuhr
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

3.  Surgical technique and post-tonsillectomy hemorrhage: a single institution's retrospective study.

Authors:  Panagiotis Saravakos; Joerg Hartwein
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-20       Impact factor: 2.503

4.  Clinical practice guideline: tonsillitis II. Surgical management.

Authors:  Jochen P Windfuhr; Nicole Toepfner; Gregor Steffen; Frank Waldfahrer; Reinhard Berner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

5.  Effect of Body Mass Index on Posttonsillectomy Hemorrhage.

Authors:  Tetsuro Hoshino; Tohru Tanigawa; Gen Yanohara; Kenta Murotani; Yuichiro Horibe; Toyoaki Murohara; Rei Shibata; Hiromi Ueda
Journal:  Biomed Res Int       Date:  2017-05-07       Impact factor: 3.411

6.  Risk factors of post-tonsillectomy hemorrhage in adults.

Authors:  Yoshiaki Inuzuka; Kunio Mizutari; Daisuke Kamide; Michiya Sato; Akihiro Shiotani
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-11-14

7.  Risk of Postoperative Bleeding in Tonsillectomy for Peritonsillar Abscess, as Opposed to in Recurrent and Chronic Tonsillitis-A Retrospective Study.

Authors:  David Slouka; Štěpánka Čejková; Jana Hanáková; Petr Hrabačka; Stanislav Kormunda; David Kalfeřt; Alena Skálová; Václav Šimánek; Radek Kucera
Journal:  Int J Environ Res Public Health       Date:  2021-02-17       Impact factor: 3.390

8.  Potential of the Novel PTA Score to Identify Patients with Peritonsillar Inflammation Profiting from Medical Treatment.

Authors:  Christoph Spiekermann; Johannes Roth; Thomas Vogl; Markus Stenner; Claudia Rudack
Journal:  Dis Markers       Date:  2018-05-28       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.